Kapake (Paracetamol, Codeine Phosphate Hemihydrate)

Paracetamol provides analgesic and antipyretic effects by centrally inhibiting cyclo‑oxygenase enzymes, which reduces prostaglandin synthesis. Codeine acts as a μ‑opioid receptor agonist, altering pain perception in the central nervous system. The two agents work together to enhance overall pain relief and fever control.

The appropriate dose of Kapake is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Patients should follow the prescriber’s instructions and never exceed the recommended amount.

Safety of Kapake in pregnancy or while breastfeeding has not been fully established. Healthcare providers should evaluate the potential benefits against possible risks before prescribing it to pregnant or nursing women. Women should discuss any concerns with their physician.

To order Kapake, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kapake offers a combination of paracetamol and codeine, providing both non‑opioid and opioid analgesia in a single tablet. Compared with paracetamol alone, it adds stronger pain relief but also carries a higher risk of opioid‑related side effects. It is an alternative to other codeine‑containing products when a dual mechanism is desired.

Kapake should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture and direct sunlight to maintain potency and stability throughout its shelf life.

Kapake is taken orally with a glass of water. It may be taken with or without food, but patients should follow the prescriber’s guidance regarding timing relative to meals to minimize gastrointestinal discomfort.

Serious risks include respiratory depression, severe allergic reactions such as anaphylaxis, hepatotoxicity in cases of overdose, and the potential for dependence or addiction with prolonged use. Patients should seek immediate medical attention if they experience difficulty breathing, rash, or signs of liver injury.

Kapake should be avoided in individuals with known hypersensitivity to paracetamol, codeine, or any excipients, in patients with severe respiratory depression, uncontrolled asthma, or significant liver disease, and in anyone taking prohibited concomitant medications listed as major interactions.